Pharmacy Freak Editorial Team

Introduction Preclinical and clinical development considerations for biologics in the USA is designed for M.Pharm students to build a clear regulatory perspective on developing biological products. This blog focuses on the US regulatory framework—FDA expectations for investigational new drug (IND) and biologics license applications (BLA)—and the nonclinical work needed: GLP toxicology, species selection, immunogenicity assessment, … Read more

Introduction: This quiz collection is designed for M.Pharm students to strengthen understanding of key US regulatory pathways: IND, BLA, PMA, NDA and 510(k). It explains how investigational new drug applications enable clinical trials, how biologics license applications differ from NDAs, and how device pathways (510(k), De Novo, PMA) determine marketing routes. Questions emphasize submission components, … Read more

Introduction This quiz set focuses on biologics and biosimilars from a USA regulatory perspective, tailored for M.Pharm students studying Regulatory Aspects of Herbal and Biologicals. It explains key definitions, pathways, and differences between original biologic products and biosimilar or interchangeable products under US law, emphasising the Biologics Price Competition and Innovation Act (BPCIA), 351(a) and … Read more

Introduction: GMP and GDP requirements for biologics in India MCQs With Answer is designed for M.Pharm students preparing for exams in Regulatory Aspects of Herbal and Biologicals (MRA202T). This quiz set focuses on Indian regulatory expectations and international best practices for manufacturing, quality control, distribution and storage of biological products. Questions emphasize facility design, contamination … Read more

Introduction This quiz set focuses on post-market data and pharmacovigilance specifically for similar biologics (biosimilars), tailored for M.Pharm students studying Regulatory Aspects of Herbal and Biologicals (MRA202T). It covers regulatory expectations for safety monitoring, risk management plans, signal detection, immunogenicity surveillance, traceability, and reporting timelines used by major agencies (e.g., EMA, WHO, CDSCO). Questions probe … Read more

Introduction Data requirements for market authorization of biologics MCQs With Answer is designed to help M.Pharm students deepen their understanding of the regulatory dossier and evidence needed to obtain approval for biologic products. This set focuses on quality, safety and efficacy documentation — including CMC, non-clinical and clinical data — as well as requirements for … Read more

Introduction: Data requirements for clinical trial applications for biologics is a crucial topic for M.Pharm students preparing for regulatory roles in the biotech and pharmaceutical industries. This blog provides a concise yet detailed overview of the types of data needed when submitting clinical trial applications for biological products, covering quality (CMC), non-clinical safety, immunogenicity assessment, … Read more

Introduction: This quiz focuses on the data requirements for preclinical studies of biologics, tailored for M.Pharm students studying Regulatory Aspects of Herbal and Biologicals (MRA202T). It covers key regulatory expectations, study design considerations, and types of nonclinical data needed to support clinical development of biologics — including species selection, pharmacology, toxicology, immunogenicity, biodistribution, and specialized … Read more

Introduction: Principles for development of similar biologics (biosimilars) MCQs With Answer This blog provides a focused set of multiple-choice questions tailored for M.Pharm students studying regulatory aspects of biologics. It covers the scientific, analytical and regulatory principles central to development of similar biologics (biosimilars), including reference product selection, critical quality attributes, analytical comparability, clinical and … Read more

Applicable regulations and guidelines for biologics in India MCQs With Answer This quiz-focused blog provides M.Pharm students with targeted multiple-choice questions on the regulatory framework that governs biologics in India. Covering key laws, regulatory authorities, national guidelines (such as the CDSCO–DBT “Guidance on Similar Biologics”), clinical trial requirements, manufacturing standards (GMP/Schedule M), and international harmonisation … Read more